0001104659-21-051578.txt : 20210419
0001104659-21-051578.hdr.sgml : 20210419
20210419060703
ACCESSION NUMBER: 0001104659-21-051578
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210414
FILED AS OF DATE: 20210419
DATE AS OF CHANGE: 20210419
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SQUINTO STEPHEN P
CENTRAL INDEX KEY: 0001231954
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39044
FILM NUMBER: 21833010
MAIL ADDRESS:
STREET 1: C/O ALEXION PHARMACEUTICALS INC
STREET 2: 352 KNOTTER DRIVE
CITY: CHESHIRE
STATE: CT
ZIP: 06410
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc.
CENTRAL INDEX KEY: 0001773427
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 203-883-9490
MAIL ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
4
1
tm2113336-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-04-14
0
0001773427
SpringWorks Therapeutics, Inc.
SWTX
0001231954
SQUINTO STEPHEN P
C/O SPRINGWORKS THERAPEUTICS, INC.,
100 WASHINGTON BLVD.
STAMFORD
CT
06902
1
0
1
0
Common Stock
2021-04-14
4
S
0
511
75.0773
D
146217
D
Common Stock
2021-04-15
4
S
0
1057
75.0147
D
145160
D
The sale transaction reported on this Form 4 was effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $75.04 to $75.41, inclusive.
Includes shares of common stock held by a trust (i) the beneficiaries of which are the Reporting Person's children and (ii) of which the Reporting Person is the trustee.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $75.00 to $75.04, inclusive.
/s/ Francis I. Perier, Jr as Attorney-in-Fact
2021-04-19